Top Markets
Coin of the day
Metsera, Inc. Metsera, Inc.

Metsera, Inc.

MTSR
Kedudukan dalam Saham #2738
Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in... Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in crafting both injectable and oral nutrient-stimulated hormone analog peptides. These therapeutic compounds are primarily aimed at addressing obesity, overweight conditions, and associated health issues. Its developmental pipeline features MET-097i and MET-233i, both under investigation for treating obesity and overweight patients. Furthermore, Metsera is advancing a potential combination therapy involving MET-233i and MET-097i. The company is also progressing additional drug candidates, including MET-002, MET-224o, MET-067i, and MET-034i, all of which target disorders such as diabetes and obesity. Founded in 2022, Metsera, Inc. maintains its corporate headquarters in New York, New York.
Harga Saham
$70.50
Disegerakkan terakhir: 2025-11-14
Modal Pasaran
$7.33B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
116.32%
Negara
US
Perdagangan Metsera, Inc. (MTSR)

Kategori

Sejarah pecahan saham untuk Metsera, Inc. (MTSR)
Saham Metsera, Inc. (simbol: MTSR) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 25, 2026.
Satu saham MTSR yang dibeli sebelum Aug 25, 2026 kini bersamaan dengan 0 saham MTSR.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH